Astro-Med, Inc. (Astronova) 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended October 29, 2005. Astro-Med, Inc. is a multi-national enterprise designing, manufacturing, and distributing data acquisition, storage, and analysis products. The company operates through three segments: Test & Measurement (T&M), QuickLabel Systems (QLS), and Grass-Telefactor (G-T).
Key Financial Metrics
| Metric | Three Months Ended Oct 29, 2005 | Nine Months Ended Oct 29, 2005 |
|---|---|---|
| Net Sales | $14,455,179 | $43,296,634 |
| Gross Profit | $5,783,672 (40.0% Margin) | $17,802,646 (41.1% Margin) |
| Operating Income | $479,683 | $1,900,196 |
| Net Income | $673,743 | $1,694,120 |
| Diluted EPS | $0.11 | $0.29 |
| Cash & Equivalents | $2,014,275 | $2,014,275 (Balance Sheet) |
| Securities Available for Sale | $11,732,920 | $11,732,920 (Balance Sheet) |
| Operating Cash Flow (9mo) | $1,043,981 | |
| Debt | No long-term debt reported; $500,000 in other long-term liabilities (escrow). |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 9.1% in the quarter and 4.0% for the nine-month period compared to the prior year. T&M sales grew 24.2% (quarterly) driven by Dash Series and Ruggedized products. G-T sales grew 10.8% (quarterly) due to clinical and sleep system demand.
- Profitability: Operating income surged to $479,683 in the quarter from $6,791 in the prior year quarter. Gross margins improved to 40.0% (quarterly) and 41.1% (nine-month) due to favorable product mix shifts.
- Tax Impact: The quarter included a $361,000 income tax benefit from the reversal of tax reserves related to favorable resolution of examinations, resulting in a net tax benefit rather than an expense for the quarter.
- Cash Flow: Operating cash flow for the nine months decreased to $1.04 million from $2.08 million in the prior year, primarily due to an increase in accounts receivable ($776k usage) and inventory build-up.
Outlook, Risks, and Unusual Items
- Real Estate Transaction: The company entered an agreement to sell 24.7 acres of land in Braintree, MA, for $6.1 million. As of the filing date, $500,000 is held in escrow. If completed, the company expects a pre-tax gain of approximately $5.4 million. The transaction is subject to zoning approvals and a 16-month timeline.
- Accounting Changes: The company is evaluating the impact of SFAS No. 123-R (Share-Based Payment), which requires fair value measurement of stock options, effective for the first annual period after June 15, 2005.
- Risks: Management cites risks including declining demand in defense/aerospace markets, competition in specialty printing and neurophysiology, and foreign currency exchange rate fluctuations.
- Dividends: The company declared dividends of $0.04 per share for the quarter ($0.12 for the nine months).
Investor Verification Checklist
- Verify the status and closing timeline of the $6.1 million land sale in Braintree, MA, and the likelihood of the $5.4 million gain recognition.
- Monitor the impact of SFAS No. 123-R adoption on future net income and EPS, as stock-based compensation will move from disclosure-only to expense recognition.
- Review the sustainability of the 24.2% growth in the T&M segment, specifically regarding the Dash Series and Ruggedized product lines.
- Assess the trend in Accounts Receivable days sales outstanding (DSO), which increased from 58 days to 63 days, indicating a slower collection cycle.
- Confirm the recurring nature of the $361,000 tax benefit; this was a one-time reversal of reserves and should not be expected in future periods.